Thesis Care, an AI-powered healthcare technology company focused on scaling clinical capacity, announced it has raised $45 million in Series A funding. The round was led by Oak HC/FT, with participation from CRV and additional backing from Black Opal Ventures and healthcare technology angel investors, bringing the company’s total funding to $60 million.
Alongside the funding, the company revealed its rebrand from Trovo Health to Thesis Care, reflecting the evolution of its platform and broader ambitions in healthcare delivery. The company’s platform combines AI agents with expert clinicians to handle complex clinical workflows and care management tasks for healthcare organizations.
Thesis Care’s technology is designed to understand clinical context, enabling personalized patient engagement and the execution of complete workflow actions. The platform integrates human clinicians in the loop when needed, allowing healthcare providers to maintain existing workflows without requiring additional training or tools. This approach is aimed at reducing administrative burden while increasing care capacity.
The company has already established partnerships with thousands of providers, including organizations such as US Heart & Vascular, Essen Health Care, Springfield Clinic, Unio Health Partners, and Allied Digestive Health. Thesis Care is now expanding its reach into health systems and health plan care teams.
With the new funding, Thesis Care plans to accelerate its commercial expansion, further develop its unified technology platform, and broaden its suite of AI-powered care team agents.
KEY QUOTES
“2025 was a defining year for Thesis as we moved from design partnerships into a clear commercial trajectory and growing customer base. We’ve proven that we can extend clinical capacity and allow our customers to do more for patients at a scale that has historically been impossible. Now, we’re ready to bring that to every healthcare organization that needs it.”
Niren Gandra, M.D., CEO And Co-Founder Of Thesis Care
“Thesis lets us deliver better care at scale – without the operational lift you’d expect. It takes real work off our staff’s plates, patients show up prepared, and care gaps get closed. What sets Thesis apart is the human care team behind the agents – that combination of automation and human judgment is what takes patient care to another level. The ROI speaks for itself.”
Shaivali Shah, SVP Of Operations At Allied Digestive Health
“As we scale USHV, we look for partners who can deliver on innovation and execution. Thesis’s combination of AI agents and care team experts allowed us to deploy solutions quickly with minimal internal lift, resulting in a tangible reduction in administrative burden and strengthened practice support.”
Mike Plantz, Senior Vice President Of Revenue Operations At U.S. Heart & Vascular
“Thesis has developed a fundamentally unique platform that addresses clinically deep, complex workflows. We are proud to continue our partnership with the Thesis team as they build the infrastructure for the future of scalable care delivery.”
Andrew Adams, Co-Founder And Managing Partner At Oak HC/FT
